Intervention
UTAA91 injection
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownThe Clinical Study on the Treatment of Refractory RA With UTAA91 InjectionNCT07001956 · 2025-05-30
RECRUITINGClinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 InjectionNCT06982547 · 2025-06-01
NOT_YET_RECRUITINGEarly Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesNCT06970951 · 2025-05-18
NOT_YET_RECRUITINGCommon conditions
Leading sponsors
Trial status mix
NOT_YET_RECRUITING2
RECRUITING1
Phase mix
EARLY_PHASE13
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.